Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

The New England Journal of Medicine
V BaracosA L Goldberg

Abstract

To clarify the mechanisms underlying the loss of body protein during fever and sepsis, we incubated rat muscles with highly purified human leukocytic pyrogen. This polypeptide, which appears identical to interleukin-1, is released by leukocytes and signals the onset of fever in the hypothalamus. In muscles incubated at 37 degrees C, leukocytic pyrogen stimulated net protein degradation by 62 to 118 per cent (P less than 0.001). Proteolysis increased, but rates of muscle-protein synthesis did not change. The pyrogen also dramatically stimulated muscle synthesis of prostaglandin E2, which promotes protein breakdown in this tissue. Addition of indomethacin with leukocytic pyrogen prevented prostaglandin E2 synthesis and abolished the increase in proteolysis. The acceleration of protein breakdown induced by pyrogen was also blocked by Ep-475, an inhibitor of lysosomal thiol proteases. When muscles were incubated at 39 degrees C to mimic fever, protein breakdown increased, but addition of leukocytic pyrogen caused a further marked increase in proteolysis and prostaglandin E2 production. Thus, human leukocytic pyrogen can act on skeletal muscle to stimulate intralysosomal proteolysis by increasing the production of prostaglandin E2. ...Continue Reading

References

Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C A DinarelloS M Wolff
Aug 1, 1979·Annals of Internal Medicine·H A BernheimE Atkins
Aug 1, 1977·The Journal of Clinical Investigation·C A DinarelloS M Wolff
Apr 1, 1977·The American Journal of Clinical Nutrition·A A Kielmann
Jan 1, 1975·Annual Review of Medicine·N B Ruderman
Jan 1, 1975·Annual Review of Medicine·W R Beisel
Jan 1, 1975·Methods in Enzymology·A L GoldbergM J Kushmerick
May 1, 1982·The American Journal of Medicine·C A Dinarello, S M Wolff
Mar 10, 1983·The New England Journal of Medicine·G H ClowesC A Saravis
Mar 1, 1980·JPEN. Journal of Parenteral and Enteral Nutrition·G H ClowesC J Cha
Jan 1, 1981·Methods in Enzymology·A L GoldbergF S Larimore
Mar 1, 1982·Inflammation·C A DinarelloS M Wolff
Sep 1, 1981·Journal of Neurochemistry·C A Dinarello, H A Bernheim
Jul 26, 1980·British Medical Journal·P J GarlickJ C Waterlow

❮ Previous
Next ❯

Citations

Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A FabbriG Marchesini
Aug 1, 1993·Journal of Cellular Physiology·A SongM A Harrington
Nov 1, 1992·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Jan 1, 1984·Rheumatology International·C P Maury
Sep 1, 1985·Journal of Clinical Immunology·C A Dinarello
Aug 11, 1993·Molecular and Cellular Biochemistry·C García-MartínezJ M Argilés
Aug 1, 1992·Digestive Diseases and Sciences·S A McClaveH L Snider
Jun 1, 1988·Digestive Diseases and Sciences·H W Kao, R D Zipser
Feb 1, 1986·World Journal of Surgery·U KellerM Heberer
Jan 1, 1988·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·J WeipertA Heidland
Jun 15, 1989·Experientia·S Masure, G Opdenakker
Sep 1, 1985·Clinical Rheumatology·A WeinbergerJ Pinkhas
Jan 1, 1989·Immunologic Research·E KaplanJ A Gelfand
May 1, 1987·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J A Vestrup
Nov 29, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·C LinnmanD Borsook
May 15, 1984·The American Journal of Medicine·J A Tayek, G L Blackburn
Dec 1, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·M HaagW H Hörl
Apr 27, 1988·European Journal of Pharmacology·H NakamuraT Kadokawa
Jun 22, 1988·European Journal of Pharmacology·H NakamuraT Kadokawa
Jul 1, 1994·The International Journal of Biochemistry·O ZamirP O Hasselgren
Oct 20, 1986·Life Sciences·C J McClainA M Kaplan
Mar 1, 1989·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A Neri
Sep 1, 1989·Physiology & Behavior·W LanghansE Scharrer
Jan 1, 1989·Prostaglandins·R RomeroM D Mitchell
Oct 1, 1991·The American Journal of Psychiatry·R J Gurrera
Jan 1, 1985·Pharmacology & Therapeutics·C G Van ArmanD H Kim
Oct 15, 1986·Immunology Letters·R M Gorczynski, E J Keystone
Jan 1, 1991·Clinical Neurology and Neurosurgery·A A Op de CoulJ L Teepen
May 1, 1985·Diagnostic Microbiology and Infectious Disease·C H Chun, M J Raff
Jan 1, 1996·Nutrition·C A Dinarello, R Roubenoff
Aug 20, 2005·The International Journal of Biochemistry & Cell Biology·Clifford PereiraDavid N Herndon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.